Lessons from rodent models in celiac disease

Mucosal Immunology

Volumn 8, Issue 1, 2015, Pages 18-28

  Korneychuk, N ^a,b   Meresse, B ^a,b   Cerf Bensussan, N ^a,b  

^a IMAGINE INSTITUTE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; GLIADIN; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 15; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SECRETORY IMMUNOGLOBULIN;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CYTOKINE PRODUCTION; GENETIC PREDISPOSITION; GLUTEN FREE DIET; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RODENT MODEL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; ANIMAL; DIET; DISEASE MODEL; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; MOUSE; RAT;

ANIMALS; CELIAC DISEASE; DIET; DISEASE MODELS, ANIMAL; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLUTENS; HUMANS; MICE; RATS;

EID: 84927651640     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.102     Document Type: Review

References (74)

1. Marietta, E. V. & Murray, J. A. Animal models to study gluten sensitivity. Semin. Immunopathol. 34, 497-511 (2012)
2. Troncone,R. & Ferguson, A. Animalmodel of gluten induced enteropathy in mice. Gut 32, 871-875 (1991)
3. Troncone, R., Caputo, N., Zibella, A., Molitierno, G., Maiuri, L. & Auricchio, S. Effects of gluten enriched diet on the small intestinal mucosa of normal mice and mice with graft versus host reaction. Gut 35, 779-782 (1994)
4. Troncone, R. & Ferguson, A. Gliadin presented via the gut induces oral tolerance in mice. Clin. Exp. Immunol. 72, 284-287 (1988)
5. Stepankova, R., Tlaskalova-Hogenova, H., Sinkora, J., Jodl, J. & Fric, P. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten. Scand. J. Gastroenterol. 31, 551-557 (1996)
6. Stepankova, R., Kofronova, O., Tuckova, L., Kozakova, H., Cebra, J. J. & Tlaskalova-Hogenova, H. Experimentally induced gluten enteropathy and protective effect of epidermal growth factor in artificially fed neonatal rats. J. Pediatr. Gastroenterol. Nutr. 36, 96-104 (2003)
7. Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275-2279 (2002)
8. Abadie, V., Sollid, L. M., Barreiro, L. B. & Jabri, B. Integration of genetic and immunological insights into amodel of celiac disease pathogenesis. Annu. Rev. Immunol. 29, 493-525 (2011)
9. Meresse, B., Malamut, G. & Cerf-Bensussan, N. Celiac disease: an immunological jigsaw. Immunity 36, 907-919 (2012)
10. Freitag, T. L. et al. Gliadin-primed CD4CD45RBlowCD25-T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice. Gut 58, 1597-1605 (2009)
11. Freitag, T. L. et al. Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G526-G534 (2014)
12. Fuchs, A. et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-gamma-producing cells. Immunity 38, 769-781 (2013)
13. Hmida, N. B. et al. Impaired control of effector Tcells by regulatory Tcells: a clue to loss of oral tolerance and autoimmunity in celiac disease. Am. J. Gastroenterol. 107, 604-611 (2012)
14. Zanzi, D. et al. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am. J. Gastroenterol. 106, 1308-1317 (2011)
15. van Leeuwen, M. A. et al. Changes in natural Foxp3()Treg but not mucosally-imprinted CD62L(neg)CD38()Foxp3()Treg in the circulation of celiac disease patients. PLoS One 8, e68432 (2013)
16. Mottet, C., Uhlig, H. H. & Powrie, F. Cutting edge: cure of colitis by CD4CD25 regulatory T cells. J. Immunol. 170, 3939-3943 (2003)
17. Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J. P. & Taurog, J. D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 63, 1099-1112 (1990)
18. Nabozny, G. H. et al. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183, 27-37 (1996)
19. Taneja, V. & David, C. S. Role of HLA class II genes in susceptibility/ resistance to inflammatory arthritis: studies with humanized mice. Immunol. Rev. 233, 62-78 (2010)
20. Cosgrove, D. et al. Mice lacking MHC class II molecules. Cell 66, 1051-1066 (1991)
21. Black, K. E., Murray, J. A. & David, C. S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169, 5595-5600 (2002)
22. Law, Y. M., Yeung, R. S., Mamalaki, C., Kioussis, D., Mak, T. W. & Flavell, R. A. Human CD4 restores normal Tcell development and function in mice deficient in murine CD4. J. Exp. Med. 179, 1233-1242 (1994)
23. van de Wal, Y. et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc. Natl. Acad. Sci. USA 95, 10050-10054 (1998)
24. van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific Tcell reactivity. J. Immunol. 161, 1585-1588 (1998)
25. Cohn, A., Sofia, A. M. & Kupfer, S. S. Type 1 diabetes and celiac disease: clinical overlap and new insights into disease pathogenesis. Curr. Diab. Rep. 14, 517 (2014)
26. Zhernakova, A., Withoff, S. & Wijmenga, C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat. Rev. Endocrinol. 9, 646-659 (2013)
27. Marietta, E. et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J. Clin. Invest. 114, 1090-1097 (2004)
28. Sardy, M., Karpati, S., Merkl, B., Paulsson, M. & Smyth, N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med. 195, 747-757 (2002)
29. Galipeau, H. J. et al. Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J. Immunol. 187, 4338-4346 (2011)
30. Hansen, C. H. et al. A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice. Diabetes 63, 2821-2832 (2014)
31. Marietta, E. V. et al. Low incidence of spontaneous type 1 diabetes in nonobese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One 8, e78687 (2013)
32. Jaakkola, I., Jalkanen, S. & Hanninen, A. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. Eur. J. Immunol. 33, 3255-3264 (2003)
33. Yang, X. D., Sytwu, H. K.,McDevitt, H. O. &Michie, S. A. Involvement of beta 7 integrin and mucosal addressin cell adhesionmolecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. Diabetes 46, 1542-1547 (1997)
34. Hanninen, A., Jaakkola, I. & Jalkanen, S. Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J. Immunol. 160, 6018-6025 (1998)
35. de Kauwe, A. L. et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4 T cells. J. Immunol. 182, 7440-7450 (2009)
36. Bodd, M., Raki, M., Bergseng, E., Jahnsen, J., Lundin, K. E. & Sollid, L. M. Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease. Eur. J. Immunol. 43, 2605-2612 (2013)
37. Du Pre, M. F. et al. Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells. Gastroenterology 141, 610-620. 20 e1-2 (2011)
38. Sjostrom, H. et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48, 111-115 (1998)
39. Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3 regulatory Tcells in the laminapropria. Immunity34,237-246(2011)
40. Abadie, V. & Jabri, B. IL-15: a central regulator of celiac disease immunopathology. Immunol. Rev. 260, 221-234 (2014)
41. Di Sabatino, A. et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55, 469-477 (2006)
42. Mention, J. J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730-745 (2003)
43. Bernardo, D. et al. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin. Exp. Immunol. 154, 64-73 (2008)
44. Hue, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367-377 (2004)
45. Meresse, B. et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366 (2004)
46. Malamut, G. et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac diseaseassociated inflammation and lymphomagenesis. J. Clin. Invest. 120, 2131-2143 (2010)
47. Ben Ahmed, M. et al. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763-6770 (2009)
48. Benahmed,M. et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132, 994-1008 (2007)
49. Fehniger, T. A. et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8 Tcells. J. Exp. Med. 193, 219-231 (2001)
50. DePaolo, R. W. et al. Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature 471, 220-224 (2011)
51. Ohta,N. et al. IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha betaNK1. 1 T cells for the development of small intestinal inflammation. J. Immunol. 169, 460-468 (2002)
52. Korneychuk, N. et al. Interleukin 15 and CD4() T cells cooperate to promote small intestinal enteropathy in response to dietary antigen. Gastroenterology 146, 1017-1027 (2014)
53. Yokoyama, S., Takada, K., Hirasawa,M., Perera, L. P. & Hiroi, T. Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease. J. Clin. Immunol. 31, 1038-1044 (2011)
54. Yokoyama, S., Perera, P. Y., Waldmann, T. A., Hiroi, T. & LP., Perera Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J. Clin. Immunol. 33, 586-594 (2013)
55. Yokoyama, S. et al. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenicmice that overexpress IL-15 in enterocytes. Proc. Natl. Acad. Sci. USA 106, 15849-15854 (2009)
56. Malamut, G., Meresse, B., Cellier, C. & Cerf-Bensussan, N. Refractory celiac disease: from bench to bedside. Semin. Immunopathol. 34, 601-613 (2012)
57. Barnden, M. J., Allison, J., Heath, W. R. & Carbone, F. R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34-40 (1998)
58. Newberry, R. D., Stenson, W. F. & Lorenz, R. G. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 5, 900-906 (1999)
59. Fina, D. et al. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887-892 (2008)
60. Bodd, M. et al. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol. 3, 594-601 (2010)
61. Sarra, M. et al. IL-15 positively regulates IL-21 production in celiac disease mucosa. Mucosal Immunol. 6, 244-255 (2013)
62. Meresse, B. et al. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343-1355 (2006)
63. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000)
64. Giersiepen, K. et al. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J. Pediatr. Gastroenterol. Nutr. 54, 229-241 (2012)
65. Matysiak-Budnik, T. et al. Secretory IgAmediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143-154 (2008)
66. Dominguez, O., Giner, M. T., Alsina, L., Martin, M. A., Lozano, J. & Plaza, A. M. Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol. An. Pediatr. 76, 261-267 (2012)
67. Lebreton, C. et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 143, 698-707. e1-e4 (2012)
68. Abed, J. et al. Abnormal apical-to-basal transport of dietary ovalbumin by secretory IgA stimulates a mucosal Th1 response. Mucosal Immunol. 7, 315-324 (2014)
69. Norouziyan, F., Shen,W. C. & Hamm-Alvarez, S. F. Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells. Am. J. Physiol. Cell Physiol. 294, C7-21 (2008)
70. Xia, C. Q. & Shen, W. C. Tyrphostin-8 enhances transferrin receptormediated transcytosis in Caco-2-cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats. Pharm. Res. 18, 191-195 (2001)
71. Tamouza, H. et al. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy. Kidney Int. 82, 1284-1296 (2012)
72. Wieser, H. Chemistry of gluten proteins. Food Microbiol. 24, 115-119 (2007)
73. Sollid, L. M., Qiao, S. W., Anderson, R. P., Gianfrani, C. & Koning, F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64, 455-460 (2012)
74. Junker, Y. et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J. Exp. Med. 209, 2395-2408 (2012).